BioCentury
ARTICLE | Finance

Broader spectrum

Japanese investors hope Prism's expansion beyond cancer will double valuation

June 17, 2013 7:00 AM UTC

Prism Pharma Co. Ltd. plans to use the $15 million it raised in a series C round last week to expand the Japanese company's focus beyond cancer and beef up its valuation.

New investor Innovation Network Corp. of Japan led the round with participation from existing investors DBJ Capital Co. Ltd., the Organization for Industry-Academia-Government Collaboration (Collabo SGK), JAFCO Co. Ltd., Neostella Capital Co. Ltd. and Angel Capital Co. Ltd...